Trump’s endorsement of Regeneron’s treatment could make matters more difficult for the drug company.
Jitendra Kumar Shah
October 09, 2020
By Unknown Author from NYT World https://ift.tt/30QfuN8
';
(function() {
var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true;
dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js';
(document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq);
})();
